Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
JOURNAL OF CROHNS & COLITIS
Journal
Overview
Research
Identity
Other
View All
Overview
publication venue for
Vedolizumab and Anti-Tumour Necrosis Factor alpha Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study
. 15:1694-1706.
2021
The relationship between vedolizumab drug concentrations at or before week 6 and remission at week 14 in ulcerative colitis patients from GEMINI 1
2016
Research
category
GASTROENTEROLOGY & HEPATOLOGY
Web of Science Category
Identity
International Standard Serial Number (ISSN)
1873-9946
Electronic International Standard Serial Number (EISSN)
1876-4479
Other
journal abbreviation
J CROHNS COLITIS